Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 733324
Species: Mus musculus
RGD Object: Gene
Symbol: Csnk2a1
Name: casein kinase 2, alpha 1 polypeptide
Acc ID: CHEBI:39867
Term: valproic acid
Definition: A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Chemical ID: MESH:D014635
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
Csnk2a1decreases expressionEXP 6480464CTDValproic Acid results in decreased expression of CSNK2A1 mRNAPMID:21427059
Csnk2a1affects expressionISOCSNK2A1 (Homo sapiens)6480464CTDValproic Acid affects the expression of CSNK2A1 mRNAPMID:25979313
Csnk2a1decreases expressionISOCSNK2A1 (Homo sapiens)6480464CTDValproic Acid results in decreased expression of CSNK2A1 mRNAPMID:23179753 PMID:26272509
Csnk2a1decreases methylationISOCSNK2A1 (Homo sapiens)6480464CTDValproic Acid results in decreased methylation of CSNK2A1 genePMID:29154799
Csnk2a1increases expressionISOCSNK2A1 (Homo sapiens)6480464CTDValproic Acid results in increased expression of CSNK2A1 mRNAPMID:29154799
Csnk2a1multiple interactionsISOCSNK2A1 (Homo sapiens)6480464CTD[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSNK2A1 mRNAPMID:27188386
Go Back to source page   Continue to Ontology report